Aelius Biotech Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$971K
- Investors
-
6
Aelius Biotech General Information
Description
Developer of a model gut system intended to help healthcare industry participants simulate digestion, mucus permeation, and epithelial absorption. The company offers a range of in vitro testing and in vivo testing, simple lab assays and routine testing, rheology, integrated model gut testing through the aerodigestive tract, and also runs human trials, enabling healthcare companies to make data-driven decisions to drive and develop and de-risk orally delivered products in development.
Contact Information
Website
www.aeliusbiotech.co.ukCorporate Office
- 12 Blandford Square
- Newcastle upon Tyne NE1 4HZ
- England, United Kingdom
Corporate Office
- 12 Blandford Square
- Newcastle upon Tyne NE1 4HZ
- England, United Kingdom
Aelius Biotech Timeline
Aelius Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 07-Apr-2025 | $971K | Completed | Generating Revenue | ||
| 3. Later Stage VC | 23-Nov-2023 | Completed | Generating Revenue | |||
| 2. Grant | 01-Apr-2022 | $272K | Completed | Startup | ||
| 1. University Spin-Out | 24-Aug-2018 | Completed | Startup |
Aelius Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aelius Biotech Patents
Aelius Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023391264-A1 | Biological modelling device | Pending | 07-Dec-2022 | ||
| EP-4630532-A1 | Biological modelling device | Pending | 07-Dec-2022 | ||
| GB-202218384-D0 | Biological modelling device | Inactive | 07-Dec-2022 | ||
| GB-2625116-A | Biological modelling device | Inactive | 07-Dec-2022 | ||
| WO-2024121557-A1 | Biological modelling device | Inactive | 07-Dec-2022 | C12M23/12 |
Aelius Biotech Signals
Aelius Biotech Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Regional Development Fund (Brandenburg) | Government | Minority | ||
| Mercia Ventures | Venture Capital | Minority | ||
| NEDFi Venture Capital | Venture Capital | Minority | ||
| North East Fund | Venture Capital | Minority | ||
| Innovate UK | Government |
Aelius Biotech Investments (1)
Aelius Biotech’s most recent deal was a Seed Round with MarraBio for . The deal was made on 18-Sep-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MarraBio | 18-Sep-2023 | Seed Round | Biotechnology |
Aelius Biotech FAQs
-
When was Aelius Biotech founded?
Aelius Biotech was founded in 2018.
-
Where is Aelius Biotech headquartered?
Aelius Biotech is headquartered in Newcastle upon Tyne, United Kingdom.
-
What is the size of Aelius Biotech?
Aelius Biotech has 16 total employees.
-
What industry is Aelius Biotech in?
Aelius Biotech’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Aelius Biotech a private or public company?
Aelius Biotech is a Private company.
-
What is Aelius Biotech’s current revenue?
The current revenue for Aelius Biotech is .
-
How much funding has Aelius Biotech raised over time?
Aelius Biotech has raised $2.51M.
-
Who are Aelius Biotech’s investors?
European Regional Development Fund (Brandenburg), Mercia Ventures, NEDFi Venture Capital, North East Fund, and Innovate UK are 5 of 6 investors who have invested in Aelius Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process